Navigation Links
MAP Pharmaceuticals Reports First Quarter of 2012 Financial Results
Date:5/4/2012

MOUNTAIN VIEW, Calif., May 4, 2012 /PRNewswire/ -- MAP Pharmaceuticals, Inc. (Nasdaq: MAPP) today announced financial results for the first quarter ended March 31, 2012.

The net loss for the first quarter ended March 31, 2012 was $17.8 million, compared to a net loss of $16.0 million during the same period in 2011. The net loss for the first quarter ended March 31, 2012 included a one-time expense of $2.8 million for the purchase of a data package relating to the propellant used for LEVADEX. MAP Pharmaceuticals had $79.0 million in cash and cash equivalents as of March 31, 2012, compared to $98.8 million as of December 31, 2011.

"Following receipt of the Complete Response letter from the FDA on March 26 for our LEVADEX NDA submission, we will meet with the FDA in the second quarter of this year and we look forward to gaining clarity around the issues raised in the letter," said Timothy S. Nelson, president and chief executive officer of MAP Pharmaceuticals. "We believe that LEVADEX has the potential to be an important treatment for many of the 30 million Americans who suffer from migraine, and we will continue to closely collaborate with the FDA to address the issues raised in the Complete Response letter as quickly as possible."

Revenues for the first quarter ended March 31, 2012 were $1.0 million, compared to $0.6 million for the same period in 2011. The revenues for both periods were due to amortization of a $60.0 million nonrefundable upfront cash payment received in February 2011, pursuant to a collaboration agreement with Allergan, Inc. entered into in January 2011.

Research and development (R&D) expenses for the first quarter ended March 31, 2012 were $11.0 million, compared to $11.6 million for the same period in 2011. The decrease in R&D expenses for the three months ended March 31, 2012 was caused primarily by a decrease in expen
'/>"/>

SOURCE MAP Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Auxilium Pharmaceuticals to Announce First Quarter 2012 Results and Conduct Conference Call on Thursday, May 10, 2012
2. Anthera Pharmaceuticals Reports 2012 First Quarter Financial Results And Provides Clinical Progress Update
3. Cadence Pharmaceuticals Reports First Quarter 2012 Financial Results
4. Savient Pharmaceuticals to Present at the Bank of America Merrill Lynch 2012 Health Care Conference
5. Cumberland Pharmaceuticals Reports First Quarter 2012 Financial Results
6. Lilly Applauds Law Enforcement Officials for their Successful Investigation and Recovery of Pharmaceuticals Stolen from Connecticut Distribution Center
7. Valeant Pharmaceuticals Reports 2012 First Quarter Financial Results
8. Optimer Pharmaceuticals to Present at the Bank of America Merrill Lynch 2012 Health Care Conference
9. Valeant Pharmaceuticals Agrees To Acquire AcneFree And Certain Assets From University Medical
10. Lexicon Pharmaceuticals Reports On Clinical Program Status And 2012 First Quarter Results
11. OTC Pharmaceuticals: Global Industry Almanac, MarketLine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... , July 01, 2015 ... announced the addition of the "Elemental Analysis ... ICP-MS), Nondestructive (XRD, OES)), Application (Life Sciences, Food ... Global Forecasts to 2020" report to their ... on the basis of types, technologies, and applications. ...
(Date:7/7/2015)... , June 30, 2015 ... has announced the addition of the ... to their offering. This patent ... Photoacoustic imaging is a safe, non-invasive, non-ionizing ... and represents a great alternative to traditional ...
(Date:7/7/2015)... , July 7, 2015 Sequent Medical, ... developing innovative devices for the treatment of neurovascular ... has joined its Board of Directors.   ... of medical device and healthcare industries experience.  He ... he has commercialized numerous leading-edge products.  His experience ...
Breaking Medicine Technology:Elemental Analysis (Organic, Inorganic) Market 2015 - Analysis & Global Forecasts to 2020 2Worldwide Biomedical Photoacoustic Imaging Patent Landscape Report 2015 2Worldwide Biomedical Photoacoustic Imaging Patent Landscape Report 2015 3Sequent Medical Appoints Mike Kleine to its Board of Directors 2Sequent Medical Appoints Mike Kleine to its Board of Directors 3
... SAN DIEGO, March 20, 2012  HUYA Bioscience International ... of China,s preeminent pharmacological researchers, Prof. Deyong Ye ... an international leader in supporting the global development ... Fudan University will focus on specific innovations coming ...
... Mylan Inc. (Nasdaq: MYL ) today ... final approval from the U.S. Food and Drug Administration ... Ibandronate Sodium Tablets, 150mg. This product is the generic ... treatment and prevention of osteoporosis in postmenopausal women. ...
Cached Medicine Technology:HUYA Bioscience Announces New Partnership with a High Profile Pharmaceutical Lab at Shanghai's Prestigious Fudan University 2HUYA Bioscience Announces New Partnership with a High Profile Pharmaceutical Lab at Shanghai's Prestigious Fudan University 3
(Date:7/7/2015)... (PRWEB) , ... July 07, 2015 , ... Difass USA, ... can help pass those long, stressful days at work is knowing that there is ... as laid back and stress free as imagined. Planning for a vacation can be ...
(Date:7/7/2015)... ... July 07, 2015 , ... Seattle-based ... have merged to form Camber Collective. Camber Collective provides strategic advisory services ... SwitchPoint’s strategy consulting expertise with Hope Consulting’s deep experience in customer insights, ...
(Date:7/7/2015)... ... July 07, 2015 , ... Quadrino Law Group is pleased ... 304, Melville, New York 11747. The new facility is a state of the ... lines. , Richard Quadrino, the firm's CEO and founder, said, "We are pleased to ...
(Date:7/7/2015)... ... July 07, 2015 , ... At the end of June Pacific Prime Renewals team in ... . This initiative, spearheaded by the Renewals Manager, Danielle Cotton, aims to not only reduce ... On this initiative Cotton explained, “We send anything between 300 and 600 pieces of paper ...
(Date:7/7/2015)... ... 2015 , ... Healthpointe is proud to announce the addition of ... pain management specialist, will be evaluating and treating patients with orthopedic complaints, such as ... his Bachelor of Science in Biology from the University of the East, Manila, Dr. ...
Breaking Medicine News(10 mins):Health News:Difass USA Offers Eight Tips to Help Relax and Enjoy Summer Vacation 2Health News:Difass USA Offers Eight Tips to Help Relax and Enjoy Summer Vacation 3Health News:SwitchPoint and Hope Consulting Have Merged to Form Camber Collective 2Health News:Pacific Prime Hong Kong Renewals Team Starts Push to go Green 2Health News:Dr. Pedro S. Alupay, M.D., Now Providing Pain Management Services at Healthpointe in Irwindale 2Health News:Dr. Pedro S. Alupay, M.D., Now Providing Pain Management Services at Healthpointe in Irwindale 3
... September 3 (HealthDay News) -- A 7-year-old San Diego boy brought ... Switzerland a couple years ago. While there, he became infected ... him vaccinated against. Upon his return to the United States, the ... a true tale -- is the type of nightmare scenario that ...
... study aimed at improving the care of muscular ... physical therapists, and researchers at the University of ... M.D., is heading the study of treatments for ... the disease that affects children. The condition, which ...
... , THURSDAY, Sept. 2 (HealthDay News) -- Many Americans ... often believing they are thinner than they really are, ... poll finds. As part of the Harris Interactive/HealthDay ... weight, from which pollsters calculated their body-mass index (BMI), ...
... , DURHAM, N.C. Millions of patients with advanced disease ... breathe more easily. But a new study from Duke ... from the intervention, and among those who do benefit, it ... oxygen or just plain old room air both offer ...
... COLUMBUS, Ohio There is yet no straightforward way ... for high-dose radiation therapies such as stereotactic radiation therapy, ... high-dose brachytherapy for prostate and other cancers., Radiation oncologists ... James Cancer Hospital and Richard J. Solove Research Institute ...
... HealthDay Reporter , THURSDAY, Sept. 2 (HealthDay News) ... about the young, possibly because it makes them feel ... time they spent with negative news about young people, ... self-esteem boost out of this," said study author Silvia ...
Cached Medicine News:Health News:Disease May Be Only a Plane Ride Away 2Health News:Disease May Be Only a Plane Ride Away 3Health News:Rochester leads international effort to improve muscular dystrophy treatment 2Health News:Rochester leads international effort to improve muscular dystrophy treatment 3Health News:Rochester leads international effort to improve muscular dystrophy treatment 4Health News:Many Americans Don't Even Know They're Fat 2Health News:Many Americans Don't Even Know They're Fat 3Health News:Study challenges value of oxygen therapy in end-of-life care 2Health News:Study challenges value of oxygen therapy in end-of-life care 3Health News:New model may simplify high-dose radiosurgery planning 2Health News:Seniors Get Boost From Bad News About the Young 2
The 920M PLUS handheld pulseoximeter provides on-the-spot bloodoximetry and heart rate readings....
Rad-5 signal extraction pulse oximeter™...
... 3100 is a small, lightweight ... worn comfortably on the patients ... activities and for overnight studies, ... WristOx is intended to give ...
The pocket-size Invacare Digit finger pulse oximeter is a convenient and economical solution to fast, reliable SpO2, pulse rate and pulse strength measurements. Its compact size is ideal for home use...
Medicine Products: